Versartis Inc (VSAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | VSAR | ASMB | ACST | ||
Company | Versartis Inc | Assembly Biosciences | Acasti Pharma | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 1.22 | 13.30 | 2.97 | ||
High | 1.30 | 13.30 | 3.08 | ||
Low | 1.18 | 12.81 | 2.88 | ||
Last | 1.19 | 13.15 | 2.96 | ||
Change | -0.02 | +0.34 | -0.07 | ||
% Change | -1.65% | +2.65% | -2.31% | ||
Volume | 349,900 | 4,500 | 13,100 | ||
20-Day Average Volume | 237,635 | 14,380 | 11,765 | ||
Previous Close | 1.21 | 12.81 | 3.03 | ||
Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
Has Options | No | No | No | ||
Technicals | |||||
20-Day Moving Average | 1.37 | 13.67 | 3.08 | ||
20-Day Raw Stochastic | 10.87% | 36.05% | 39.74% | ||
20-Day Relative Strength | 32.11% | 50.03% | 44.15% | ||
Weighted Alpha | -62.20 | +1.54 | -26.32 | ||
Today's Opinion | N/A | 56% Buy | 40% Buy | ||
Previous Opinion | N/A | 56% Buy | 40% Buy | ||
Last Month's Opinion | N/A | 88% Buy | 96% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -8.46% since 10/08/18 | +3.95% since 04/26/24 | +2.07% since 04/26/24 | ||
Low | 1.14 on 10/12/18 | 12.18 on 04/30/24 | 2.65 on 04/30/24 | ||
High | 1.36 on 10/10/18 | 13.50 on 04/29/24 | 3.11 on 05/02/24 | ||
1-Month | |||||
%Chg | -17.93% since 09/14/18 | -4.64% since 04/03/24 | -12.43% since 04/03/24 | ||
Low | 1.14 on 10/12/18 | 12.00 on 04/26/24 | 2.65 on 04/30/24 | ||
High | 1.60 on 09/27/18 | 15.19 on 04/15/24 | 3.46 on 04/04/24 | ||
3-Month | |||||
%Chg | -41.95% since 07/13/18 | +10.69% since 02/02/24 | +24.37% since 02/02/24 | ||
Low | 1.14 on 10/12/18 | 9.84 on 02/08/24 | 2.25 on 02/05/24 | ||
High | 2.10 on 07/24/18 | 15.19 on 04/15/24 | 3.59 on 02/22/24 | ||
6-Month | |||||
%Chg | -26.77% since 04/13/18 | +25.70% since 11/03/23 | +23.33% since 11/03/23 | ||
Low | 1.14 on 10/12/18 | 7.69 on 11/22/23 | 1.98 on 01/17/24 | ||
High | 2.55 on 06/18/18 | 15.19 on 04/15/24 | 3.59 on 02/22/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 43,126 | 70,235 | 28,480 | ||
Shares Outstanding, K | 36,240 | 5,483 | 9,399 | ||
Annual Sales | 40,000,000 | 7,160,000 | 0 | ||
Annual Net Income | -84,980,000 | -61,230,000 | -42,430,000 | ||
Last Quarter Sales | N/A | 7,160,000 | 0 | ||
Last Quarter Net Income | N/A | -10,960,000 | -2,390,000 | ||
60-Month Beta | 1.94 | 0.60 | 1.55 | ||
Per-Share Information | |||||
Most Recent Earnings | -1.40 on 10/26/17 | -3.24 on 11/08/23 | -0.21 on 02/12/24 | ||
Latest Earnings Date | 10/25/18 | 05/02/24 | 02/13/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |